Wall Street analyst estimates for Unum Group (UNM): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Unum Group, along with its various subsidiaries, specializes in delivering financial protection benefits, primarily operating across the United States, the United Kingdom, and Poland. The company's operations are organized into distinct segments: Unum US, Unum International, Colonial Life, and the Closed Block. Its extensive product portfolio encompasses group coverage, including long-term and short-term disability, life insurance, and accidental death and dismemberment.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2026E | $11.9B | $11.6B – $12.5B | $8.66 | 8 |
| 2027E | $12.4B | $12.3B – $12.5B | $9.43 | 8 |
| 2028E | $13.2B | $12.8B – $14.5B | $10.41 | 5 |
Figures in USD · consensus as of November 1, 2026
Analyst Consensus
| Strong Buy | 1 |
| Buy | 14 |
| Hold | 14 |
| Sell | 1 |
| Strong Sell | 0 |
| Total analysts | 30 |
| Avg rating (−2 sell to +2 buy) | 0.50 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-03 | $2.17 | ||
| 2026-07-28 | $2.16 | $2.16 | +0.0% |
| 2026-04-28 | $2.14 | $2.05 | +4.4% |
| 2026-02-05 | $1.92 | $2.11 | -9.0% |
| 2025-11-03 | $2.09 | $2.15 | -2.8% |
| 2025-07-29 | $2.07 | $2.23 | -7.2% |
| 2025-04-29 | $2.04 | $2.19 | -6.8% |
| 2025-02-04 | $2.03 | $2.14 | -5.1% |
Valuation Ratios
| P/E Ratio | 21.22 |
| Price / Book | 1.34 |
| Dividend Yield | 2.12% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.05B | $11.29B | $11.60B | $11.99B | $13.15B | $11.84B | $11.88B | $12.31B | $12.79B | $13.05B |
| Cost of Revenue | $7.87B | $8.02B | $9.03B | $8.57B | $10.06B | $8.52B | $7.95B | $8.28B | $8.05B | $8.07B |
| Gross Profit | $3.18B | $3.27B | $2.57B | $3.42B | $3.09B | $3.32B | $3.93B | $4.03B | $4.74B | $4.99B |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | $839.1M | $852.3M | $885.9M | $898.3M | $953.2M | $975.2M | $1.09B | $1.16B | $1.17B | 0 |
| Operating Expenses | $1.83B | $1.87B | $1.94B | $2.04B | $2.12B | $2.06B | $2.18B | $2.39B | $2.49B | $4.06B |
| Operating Income | $1.35B | $1.40B | $627.8M | $1.38B | $964.0M | $1.26B | $1.75B | $1.64B | $2.25B | $933.5M |
| EBITDA | $1.62B | $1.67B | $896.5M | $1.67B | $1.27B | $1.57B | $2.05B | $1.94B | $2.57B | $1.27B |
| Interest Expense | $166.0M | $159.9M | $167.3M | $177.4M | $188.2M | $185.0M | $188.5M | $194.8M | $201.1M | $208.8M |
| Pre-tax Income | $1.35B | $1.40B | $627.8M | $1.38B | $964.0M | $1.26B | $1.75B | $1.64B | $2.25B | $933.5M |
| Income Tax | $416.3M | $409.8M | $104.4M | $281.8M | $171.0M | $279.6M | $342.8M | $356.3M | $472.2M | $195.0M |
| Net Income | $931.4M | $994.2M | $523.4M | $1.10B | $793.0M | $981.0M | $1.41B | $1.28B | $1.78B | $738.5M |
| EPS | $3.96 | $4.39 | $2.38 | $5.25 | $3.89 | $4.04 | $7.01 | $6.53 | $9.49 | $4.28 |
| EPS (Diluted) | $3.95 | $4.37 | $2.38 | $5.24 | $3.89 | $4.02 | $6.96 | $6.50 | $9.46 | $4.28 |
| Shares Outstanding (Diluted) | 236.0 M | 227.3 M | 220.1 M | 209.9 M | 203.8 M | 204.8 M | 202.1 M | 197.6 M | 188.1 M | 172.9 M |
Price
| Price | $91.02 (closing price, November 2, 2026) |
| Market Cap | $14.4B |
| Exchange | NYSE |
| Country | US |
Related companies: MFC · AFL · MET · PUK · PRU · VOYA · LNC · CNO
Explore sector: Financial Services · Insurance - Life
More sections of UNM: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks